A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects with Early Alzheimer's Disease

Grants and Contracts Details

StatusActive
Effective start/end date12/3/217/26/23

Funding

  • Novo Nordisk Pharmaceuticals Inc: $14,692.00